Influenza (flu) is a contagious respiratory illness caused by influenza viruses. It can cause mild to severe illness. Serious outcomes of flu infection can result in hospitalization or death. Some people, such as older people, young children, and people with certain health conditions, are at high risk of serious flu complications. There are two main types of influenza (flu) virus: Types A and B. The influenza A and B viruses that routinely spread in people (human influenza viruses) are responsible for seasonal flu epidemics each year.
The best way to prevent flu is by getting vaccinated each year.
Cat. No. | Product Name | CAS No. | Information |
---|---|---|---|
H4367 |
Verdinexor |
1392136-43-4 | Verdinexor (KPT-335, KPT335) is an orally bioavailable, selective inhibitor of nuclear export (SINE), inhibits the function of nuclear export protein Exportin 1 (XPO1/CRM1) and the viability of Jurkat and canine DLBCL cells with IC50 of 8.7 nM and 13.3 nM, respectively; induces apoptosis in CLBL1 cells and primary canine DLBCL cells; reduces influenza a virus replication in vitro and in vivo; also inhibits XPO1-mediated transport and reduces RSV replication in vitro, shows effectivity against RSV A and B strains and reduces viral replication following prophylactic or therapeutic administration. |
H1448 |
Zanamivir |
139110-80-8 | Zanamivir is a hihly potent, broad-spetrum influenza viral neuraminidase (NA) inhibitor with IC50 of 0.95 nM and 2.7 nM for influenza A and B, respectively; inhibits plaque formation by laboratory-passaged strains of influenza A and B viruses,IC50 ranging from 0.005 to 0.014 uM; interacts with a group of amino acids in the active site of neuraminidase, which are conserved in all influenza A and B strains. Zanamivir blocks the action of neuraminidase, which prevents the cleavage of sialic acid on the cell receptors, thus preventing release and spread of the newly formed virions. |
H1442 |
Pimodivir |
1629869-44-8 | Pimodivir (VX-787, JNJ872, JNJ 63623872) is a first-in-class, orally bioavailable inhibitor of influenza virus polymerase PB2 subunit with Kd of <3 nM, CPE EC50 of 2 nM; shows strong potency versus multiple influenza A strains, including pandemic 2009 H1N1 and avian H5N1 flu strains with mean CPE EC50 of <2 nM; Pimodivir (VX-787) is highly efficacious in both prophylaxis and treatment models of mouse influenza and is superior to the neuraminidase inhibitor Oseltamivir.l |
H1441 |
Peramivir trihydrate |
1041434-82-5 |
Peramivir (RWJ-270201, BCX-1812) is an inhibitor of influenza neuraminidase that prevents new viral particles from being released; an antiviral agent used to treat and prevent influenza A and influenza B. |
H1440 |
Peramivir |
330600-85-6 |
Peramivir (RWJ-270201, BCX-1812) is an inhibitor of influenza neuraminidase that prevents new viral particles from being released; an antiviral agent used to treat and prevent influenza A and influenza B. |
H1439 |
Oseltamivir phosphate |
204255-11-8 | A competitive inhibitor of influenza neuraminidase that prevents new viral particles from being released; an antiviral agent used to treat and prevent influenza A and influenza B. |
H1437 |
Nucleozin |
341001-38-5 | A small-molecule influenza A nucleoprotein (NP) inhibitor that triggers the aggregation of NP and inhibits its nuclear accumulation; inhibits infection of MDCK cells by viruses influenza A/WSN/33, H3N2 (clinical isolate) and Vietnam/1194/04 (H5N1) with EC50 of 0.069 uM, 0.16 uM and 0.33 uM in PRA, respectively; protects mice challenged with lethal doses of avian influenza A H5N1; also targets cytoplasmic trafficking of viral ribonucleoprotein-Rab11 complexes in influenza A virus infection. |
H1434 |
Laninamivir |
203120-46-1 | Laninamivir (CS-8958) is a prodrug of the influenza neuraminidase (NA) inhibitor R-125489, shows long-acting anti-influenza virus activity. |
H1432 |
Favipiravir |
259793-96-9 | Favipiravir (T705) is a pyrazinecarboxamide derivative that is active against influenza viruses, West Nile virus, yellow fever virus, foot-and-mouth disease virus as well as other flaviviruses, arenaviruses, bunyaviruses and alphaviruses; shows potent inhibitory activity against influenza A, B, and C viruses, with IC50s of 0.013 to 0.48 ug/ml. |
H1430 |
Baloxavir Marboxil |
1985606-14-1 |
Baloxavir Marboxil (S-033188, Xofluza) is the prodrug of Baloxavir acid (S-033447) that potently and selectively inhibits the cap-dependent endonuclease within the polymerase PA subunit of influenza A and B viruses. |
086-18516630705
sales@hmobio.com
1/F, building 4, No. 358-368, Kefu Road, Jiading District, Shanghai, China